Skip Navigation


NDT Advance Access originally published online on August 12, 2008
Nephrology Dialysis Transplantation 2009 24(1):149-155; doi:10.1093/ndt/gfn459
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/1/149    most recent
gfn459v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by González, E.
Right arrow Articles by Girardin, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by González, E.
Right arrow Articles by Girardin, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood

Elsa González1, Thomas Neuhaus2, Markus J. Kemper2 and Eric Girardin1

1 Pediatric Nephrology Unit, Department of Pediatrics, Children's Hospital, Geneva 2 Pediatric Nephrology Unit, Kinderspital, Zurich, Switzerland

Elsa González, Pediatric Nephrology Unit, Department of Pediatrics, Children's Hospital, 6 rue Willy-Donzé, 1211 Geneva 14, Switzerland. Tel: +41-22-382-46-03; Fax: +41-22-382-45-05; E-mail: ElsaGonzalez{at}mednet.ucla.edu



  Abstract

Background/Aims. Recently, peripheral blood mononuclear cell transcriptome analysis has identified genes that are upregulated in relapsing minimal-change nephrotic syndrome (MCNS). In order to investigate protein expression in peripheral blood mononuclear cells (PBMC) from relapsing MCNS patients, we performed proteomic comparisons of PBMC from patients with MCNS in relapse and controls.

Methods. PBMC from a total of 20 patients were analysed. PBMC were taken from five patients with relapsing MCNS, four in remission, five patients with other glomerular diseases and six controls. Two dimensional electrophoresis was performed and proteome patterns were compared.

Results. Automatic heuristic clustering analysis allowed us to pool correctly the gels from the MCNS patients in the relapse and in the control groups. Using hierarchical population matching, nine spots were found to be increased in PBMC from MCNS patients in relapse. Four spots were identified by mass spectrometry. Three of the four proteins identified (L-plastin, {alpha}-tropomyosin and annexin III) were cytoskeletal-associated proteins. Using western blot and immunochemistry, L-plastin and {alpha}-tropomyosin 3 concentrations were found to be enhanced in PBMC from MCNS patients in relapse.

Conclusions. These data indicate that a specific proteomic profile characterizes PBMC from MCNS patients in relapse. Proteins involved in PBMC cytoskeletal rearrangement are increased in relapsing MCNS. We hypothesize that T-cell cytoskeletal rearrangement may play a role in the pathogenesis of MCNS by altering the expression of cell surface receptors and by modifying the interaction of these cells with glomerular cells.

Keywords: cytoskeleton; L-plastin; minimal-change nephrotic syndrome; mononuclear cells

Received for publication: 15. 8.07
Accepted in revised form: 17. 7.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.